
Early-stage B2B venture capital firm backed by experienced enterprise operators who invest alongside it

A global healthcare-focused venture capital and private equity firm investing across the United States and China

LYZZ Capital is a healthcare-focused venture capital and private equity firm, investing through funds denominated in both US and Chinese currencies. Its team is made up of investment and operating professionals with backgrounds at pharmaceutical and biotechnology companies as well as Wall Street firms, combining scientific, medical and financial expertise, and has worked together for more than a decade in what it describes as a cordial, team-oriented environment. The team's biotechnology investing experience extends back more than 20 years, including over 15 years working in China. The firm says it invests in talent, assets and technologies on a global basis, with particular emphasis on unmet medical needs and substantial market opportunities specifically within China.
Summary written by TrustList from the business's own published information, Sep 2026.
2 images - click to enlarge
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about LYZZ Capital.
Similar listings buyers compare against this one.

Early-stage B2B venture capital firm backed by experienced enterprise operators who invest alongside it

Early-stage venture fund based in Singapore and Helsinki investing across Asia, the USA and Europe

Open-source blockchain with its own digital currency, digital assets, smart contracts and secure authentication

A venture firm investing in consumer products and services for family health and wellbeing

Pan-African early-stage venture firm backing tech-enabled startups led by African founders

Seattle venture firm investing in cancer biotechnology and established technology companies
Everything here links back to the same verified catalogue. Pick your next stop.